This compounds and tends to make it untenable to continue both medications, at which point you have a choice to make
Side effects dealt with retroactively, not proactively
On the other hand, this rapid increase in visits, and ultimately rapid increase in prescribing of our GLP-1s led us to a sticky situation
Neural Regener Res (2020) 15(7):13339
To view a copy of this licence, visit About this article Cite this article Menafra, D., de Angelis, C., Garifalos, F
Patients in the semaglutide treatment arm of STEP 1 were more likely to be exposed to the medication at the full dose of 2.4 mg than those in SELECT